Global Trust Asset Management, LLC Vertex Pharmaceuticals Inc Transaction History

Global Trust Asset Management, LLC

  • $160 Million
  • Q1 2025

A detailed history of Global Trust Asset Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Global Trust Asset Management, LLC holds 633 shares of VRTX stock, worth $279,070. This represents 0.19% of its overall portfolio holdings.

Number of Shares
633
Previous 647 2.16%
Holding current value
$279,070
Previous $260,000 17.69%
% of portfolio
0.19%
Previous 0.1%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 18, 2025
SELL
$402.49 - $513.76 $5,634 - $7,192
-14 Reduced 2.16%
633 $306,000
Q4 2024

Jan 17, 2025
SELL
$396.64 - $516.74 $154,689 - $201,528
-390 Reduced 37.61%
647 $260,000
Q3 2024

Oct 23, 2024
BUY
$460.0 - $505.78 $101,200 - $111,271
220 Added 26.93%
1,037 $482,000
Q2 2024

Jul 11, 2024
SELL
$392.81 - $485.53 $5,892 - $7,282
-15 Reduced 1.8%
817 $382,000
Q1 2024

Apr 12, 2024
SELL
$407.69 - $446.08 $338,382 - $370,246
-830 Reduced 49.94%
832 $347,000
Q4 2023

Jan 16, 2024
SELL
$343.0 - $410.68 $29,155 - $34,907
-85 Reduced 4.87%
1,662 $676,000
Q3 2023

Oct 12, 2023
SELL
$338.18 - $362.46 $25,363 - $27,184
-75 Reduced 4.12%
1,747 $607,000
Q2 2023

Jul 24, 2023
SELL
$314.42 - $351.91 $4,716 - $5,278
-15 Reduced 0.82%
1,822 $641,000
Q1 2023

Apr 14, 2023
BUY
$283.23 - $323.1 $28,323 - $32,310
100 Added 5.76%
1,837 $578,000
Q4 2022

Feb 14, 2023
SELL
$285.76 - $321.48 $90,014 - $101,266
-315 Reduced 15.35%
1,737 $501,000
Q3 2022

Oct 07, 2022
BUY
$273.83 - $305.53 $13,691 - $15,276
50 Added 2.5%
2,052 $594,000
Q2 2022

Jul 12, 2022
SELL
$234.96 - $292.55 $246,708 - $307,177
-1,050 Reduced 34.4%
2,002 $564,000
Q1 2022

Apr 12, 2022
BUY
$221.42 - $260.97 $635,032 - $748,461
2,868 Added 1558.7%
3,052 $796,000
Q4 2021

Jan 18, 2022
BUY
$177.01 - $223.45 $20,356 - $25,696
115 Added 166.67%
184 $40,000
Q2 2021

Jul 13, 2021
BUY
$187.49 - $221.1 $12,936 - $15,255
69 New
69 $14,000
Q3 2020

Nov 17, 2020
SELL
$255.65 - $303.1 $325,953 - $386,452
-1,275 Closed
0 $0
Q2 2020

Jul 08, 2020
SELL
$225.48 - $295.8 $197,295 - $258,825
-875 Reduced 40.7%
1,275 $370,000
Q1 2020

Apr 06, 2020
BUY
$199.77 - $247.81 $429,505 - $532,791
2,150 New
2,150 $499,000
Q1 2019

Apr 05, 2019
SELL
$163.73 - $194.7 $10,314 - $12,266
-63 Closed
0 $0
Q4 2017

Feb 02, 2018
BUY
$137.28 - $155.55 $8,648 - $9,799
63
63 $9,000

Others Institutions Holding VRTX

# of Institutions
1,833
Shares Held
233M
Call Options Held
1.38M
Put Options Held
1.08M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $113B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Global Trust Asset Management, LLC Portfolio

Follow Global Trust Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Trust Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Global Trust Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email